Related content

Letter to the Editor re: Positron Emission Tomography with [¹⁸F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study

By Chalkidou A.   Mikhaeel G.   O’Doherty M.   Marsden P.  

Molecular Imaging and Biology, Vol. 15, Iss. 5, 2013-10 ,pp. : 521-522

Springer Publishing Company

Access to resources Recommend Favorite

Positron Emission Tomography with [ 18 F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study

By Dehdashti Farrokh  

Molecular Imaging and Biology, Vol. 15, Iss. 1, 2013-02 ,pp. : 106-113

Springer Publishing Company

Access to resources Recommend Favorite

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[¹⁸F]fluorothymidine positron emission tomography

By Kenny Laura   Coombes R.   Vigushin David   Al-Nahhas Adil   Shousha Sami   Aboagye Eric  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 9, 2007-09 ,pp. : 1339-1347

Springer Publishing Company

Access to resources Recommend Favorite

Changes in ¹⁸F-fluorothymidine and ¹⁸F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy

By Hoshikawa Hiroshi   Mori Terushige   Kishino Takehito   Yamamoto Yuka   Inamoto Ryuhei   Akiyama Kosuke   Mori Nozomu   Nishiyama Yoshihiro  

Annals of Nuclear Medicine, Vol. 27, Iss. 4, 2013-05 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite

Is 3′-deoxy-3′-¹⁸F-fluorothymidine a better marker for tumour response than ¹⁸F-fluorodeoxyglucose?

By Reske Sven   Deisenhofer Sandra  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 1, 2006-07 ,pp. : 38-43

Springer Publishing Company

Access to resources Recommend Favorite